Navigation Links
CareFusion Reaches Agreement In Principle On Previously Disclosed Matter With Federal Government
Date:4/25/2013

SAN DIEGO, April 25, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced an agreement in principle to resolve previously disclosed government investigations related to prior sales and marketing practices for its ChloraPrep® skin preparation product and its relationships with health care professionals.

The company expects to pay the government approximately $41 million to resolve the allegations. CareFusion will record the charge in the third quarter of fiscal 2013 to establish a reserve for this amount. In connection with these matters, CareFusion has entered into a non-prosecution agreement and will continue to cooperate with the government.

"We are pleased to have reached this important milestone as we continue to build our foundation for future growth," said Kieran T. Gallahue , chairman and CEO. "Since our spinoff, we have made significant investments to improve our quality systems, including our sales and marketing practices, and we remain committed to adhering to the highest standards."

The agreement in principle remains subject to several conditions, including the completion and execution of a formal settlement agreement and other required documentation. The amount and timing of the payment are subject to the final terms of the settlement agreement.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

Cautions Concerning Forward-looking Statements

The CareFusion news release and the information contained herein present "forward-looking statements" addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. Forward-looking statements include, but are not limited to, statements regarding the agreement in principle with the government, including the proposed settlement terms, the timing of the settlement agreement and the payment amount. CareFusion intends forward-looking terminology such as "believes," "expects," "may," "will," "should," "anticipates," "plans," or similar expressions to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause the company's actual results to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to, the company and the government may not complete the required documentation or finalize the settlement on the proposed terms or timing, or at all, as well as other risks described more fully in Item 1A in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2012, which are expressly incorporated herein by reference, and other factors as may periodically be described in the company's filings with the SEC. The CareFusion news release and the information contained herein reflect management's views as of April 25, 2013. Except to the limited extent required by applicable law, CareFusion undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE CareFusion Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion to Report Third Quarter Fiscal 2013 Results on May 9
2. CareFusion Launches New Take-Apart Laparoscopic Scissors
3. CareFusion Reports First Half Fiscal 2013 Results
4. CareFusion Files Fiscal 2012 Form 10-K
5. CareFusion Launches New Preoperative Cleansing Program For In-Home Patient Use
6. CareFusion Reports Preliminary First Quarter Fiscal 2013 Results
7. CareFusion To Report Preliminary Fiscal 2013 First Quarter Results On Nov. 8
8. CareFusion Provides Update On Form 10-K Filing
9. CareFusion Recognizes Best Of The Best U.S. Hospitals
10. CareFusion Reports Fourth Quarter and Fiscal 2012 Results
11. CareFusion To Report Fourth Quarter And Fiscal 2012 Results On Aug. 9
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... -- Dealmed Medical Supplies, New York City,s ... drugs, vaccines, and specialty medical products and services, announced ... acquire Vantage Medical Supplies, a major distributor of medical ... York . ... practices, will operate under the Dealmed name as of ...
(Date:9/7/2017)... 2017 Caris Life Sciences, a leading ... promise of precision medicine, today announced results from ... its molecular profiling approach in guiding therapeutic strategies ... plus (CGP+) with Caris Molecular Intelligence ® ... molecular level, leading to more therapeutic options and ...
Breaking Medicine Technology:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “They Sang ... the hunt for a murderer starts revealing the skeletons in their closets. “They Sang ... manager, who is now fifty-six years young and married with five children and twelve ...
(Date:9/19/2017)... ... September 19, 2017 , ... With a series ... raised more than $15,000 in just a couple of weeks for those affected ... and world-class instructor seminars, organizers expect to double those initial funds with the ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola ... strategic marketing leader, Denise Flannery, to its strategic advisory and client development team. ... Denise will work with clients across different industries to develop and implement market-justified ...
(Date:9/19/2017)... ... 19, 2017 , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two important ... excess of $835 million in resolved debt for its clients. , Credit card debt, ... the categories of debt settled by the company. With more than a decade of ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... team as the President of its HealthBI division. McFarland will grow the ... centers. , “Scott is a utility player who balances his day as ...
Breaking Medicine News(10 mins):